Daewon Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	47,196	17,057	29,982	26,970	41,697
Short-Term Investments	29,279	29,051	47.71	20,036	13,123
Cash & Short-Term Investments	76,475	46,108	30,030	47,006	54,820
Cash Growth	65.86%	53.54%	-36.11%	-14.26%	421.08%
Accounts Receivable	77,119	73,355	70,602	62,533	52,102
Other Receivables	2,591	4,317	2,580	3,906	2,363
Receivables	80,293	77,877	73,382	66,840	54,584
Inventory	97,832	113,166	105,078	91,847	69,690
Prepaid Expenses	759.55	716.31	488.39	426.61	353.29
Other Current Assets	1,243	1,486	314.56	1,165	929.46
Total Current Assets	256,603	239,353	209,293	207,284	180,377
Property, Plant & Equipment	222,902	208,378	160,092	158,912	166,674
Long-Term Investments	56,898	48,621	84,647	36,443	28,081
Goodwill	6,000	5,549	7,254	11,328	11,549
Other Intangible Assets	30,693	29,191	16,121	13,603	13,916
Long-Term Deferred Tax Assets	12,452	8,540	7,985	6,694	9,616
Long-Term Deferred Charges	25,783	20,057	18,096	15,142	14,977
Other Long-Term Assets	2,320	23,701	4,510	4,144	4,390
Total Assets	613,651	583,389	507,998	453,550	429,580
Accounts Payable	30,283	20,913	20,910	19,583	17,222
Accrued Expenses	6,226	5,686	4,885	4,352	3,741
Short-Term Debt	105,740	106,035	69,651	52,768	42,543
Current Portion of Long-Term Debt	9,477	12,917	39,803	9,284	8,822
Current Portion of Leases	1,864	1,800	1,123	1,344	362.95
Current Income Taxes Payable	487.51	4,403	2,485	4,913	4,367
Other Current Liabilities	62,261	49,023	43,833	35,903	25,019
Total Current Liabilities	216,337	200,776	182,690	128,146	102,076
Long-Term Debt	82,870	63,626	34,575	52,119	69,625
Long-Term Leases	2,085	2,863	897.72	961.42	2,616
Pension & Post-Retirement Benefits	31,205	27,792	25,497	23,478	36,780
Other Long-Term Liabilities	6,576	3,753	73.5	80	80
Total Liabilities	339,073	298,811	243,734	204,785	211,176
Common Stock	11,214	11,214	11,095	10,982	10,612
Additional Paid-In Capital	17,962	17,161	13,483	11,789	9,530
Retained Earnings	251,407	262,077	255,790	241,595	204,827
Treasury Stock	-15,100	-15,063	-15,063	-15,063	-8,891
Comprehensive Income & Other	435.68	-104.76	892.92	1,643	3,221
Total Common Equity	265,918	275,285	266,199	250,947	219,299
Minority Interest	8,660	9,294	-1,934	-2,182	-894.85
Shareholders' Equity	274,578	284,578	264,264	248,765	218,404
Total Liabilities & Equity	613,651	583,389	507,998	453,550	429,580
Total Debt	202,034	187,241	146,050	116,476	123,968
Net Cash (Debt)	-125,559	-141,133	-116,020	-69,471	-69,148
Net Cash Per Share	-5858.09	-6629.05	-5356.37	-3175.72	-3258.76
Filing Date Shares Outstanding	21.43	21.43	21.2	20.97	20.6
Total Common Shares Outstanding	21.43	21.43	21.2	20.97	21.22
Working Capital	40,266	38,577	26,603	79,137	78,301
Book Value Per Share	12406.70	12843.70	12558.89	11966.66	10335.27
Tangible Book Value	229,226	240,544	242,823	226,017	193,833
Tangible Book Value Per Share	10694.77	11222.85	11456.07	10777.82	9135.12
Land	51,414	51,414	36,957	36,957	37,055
Buildings	145,397	122,341	107,803	107,710	79,558
Machinery	138,403	114,900	101,791	100,149	41,553
Construction In Progress	11,630	29,613	10,692	778.36	1,585

Source: S&P Global Market Intelligence. Standard template. Financial Sources.